Did you mean biotin and nadide and panthenol and pyrithione zinc?
Displaying drugs 13651 - 13675 of 14615 in total
IPH 1101
IPH 1101 is a chemically-synthesized structural analog of non-conventional bacterial phosphoantigens which specifically activate the Vγ9Vδ2 T cell subset. IPH 1101 is the most advanced drug candidate of the γδ T cell platform
Investigational
Transcrocetinate
Vitamin A-analog that increases diffusivity of oxygen in aqueous solutions, including plasma.
Investigational
Idraparinux
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Description: … It was developed for the treatment and prevention of thromboembolic events. …
CRA_10991
Experimental
3h-Indole-5,6-Diol
Experimental
Xylose-derived lactam oxime
Experimental
3-Methylpyridine
Experimental
D-gluconhydroximo-1,5-lactam
Experimental
Hydrogenobyrinic acid
Experimental
Indirubin-5-sulphonate
Experimental
Siroheme
Experimental
2-Acetyl-Protoporphyrin Ix
Experimental
IC261
Experimental
Carbazole Butanoic Acid
Experimental
N-acetylserotonin
Experimental
Indole
Experimental
Displaying drugs 13651 - 13675 of 14615 in total